摘要
背景:近年来可诱导共刺激分子(inducible costimulator,ICOS)/可诱导共刺激分子配体(ICOS Ligand,ICOSL)在抗感染、抗移植反应、抗肿瘤、治疗自身免疫性疾病等多方面领域受到了越来越多的关注。目前对ICOS/ICOSL表达量的研究大多基于分子水平,国内外尚鲜见ICOS/ICOSLmRNA定量检测的报道。目的:构建ICOS/ICOSLcDNA质粒标准品,建立Taqman探针检测ICOSL/ICOSL基因表达量的方法。方法:以胃腺癌组织总RNA为模板、Random9mers为引物反转录合成cDNA,用该cDNA为模板聚合酶链反应扩增人ICOS/ICOSL基因相应的cDNA目的片段,构建PMD-18-ICOS/ICOSL重组质粒,鉴定测序后,用Taqman探针实时荧光定量聚合酶链反应制作标准曲线。结果与结论:组织提取的总RNA完整性良好,构建的ICOS/ICOSL质粒测序结果与目的片段一致,质粒的原始浓度为6.10×1013,4.31×1013copies/mL,倍比稀释后用Taqman探针荧光定量聚合酶链反应检测,在1012~1013copies/mL线性关系良好(R2=1),提示成功建立了Taqman探针定量检测ICOS/ICOSL基因表达的方法。
BACKGROUND: The inducible costimulatory molecule (ICOS) / its ligand (ICOSL) become more and more attractive in the field of anti-infection, anti-transplantation reaction, anti-tumor and treatment of autoimmune disease. Current studies focus on molecular level of ICOS/ICOSL gene expression, no study reports quantitative detection of ICOS/ICOSL mRNA expression. OBJECTIVE: To construct the plasmid standard samples of ICOS/ICOSL cDNA, and to detect the ICOS/ICOSL gene expression by the Taqman Probe technology. METHODS: The cDNA was synthesized by reverse transcription with Random 9 mers as the primer and total RNA from the gastric adenocarcinoma tissues as the template. The target sequences of human ICOS/ICOSL cDNA were amplified by polymerase chain reaction amplification from the resulting cDNA as mentioned above. The PMD-18-ICOS/ICOSL recombinant plasmids were constructed. Standard curve was made by Taqman Probe fluorescence polymerase chain reaction technology after gene sequencing. RESULT AND CONCLUSION: The composition of total RNA extracted from the tissues was complete and the sequences of the ICOS/ICOSL plasmid were consistent with the target fragments. The initial concentration of plasmids was 6.10×1013, 4.31×1013 copies/mL. The different diluted concentration of the plasmids had good linear relationship (R2=1) after amplifying by Taqman PCR and the linear range was 1012-1013 copies/mL, suggesting that the method which can quantitatively detect the concentration of ICOS/ICOSL gene by Taqman Probe technology was successfully constructed.
出处
《中国组织工程研究与临床康复》
CAS
CSCD
北大核心
2010年第31期5849-5852,共4页
Journal of Clinical Rehabilitative Tissue Engineering Research